The Andean Community approved Decision 833 that establishes the requirements and procedures that cosmetic products manufacturers in Bolivia, Colombia, Ecuador, Perú, and foreign countries must meet in order to market their products within the Andean region.

Decision 833 “Harmonization of legislation on cosmetic products”, approved during the meeting of the Commission of the Andean Community held in Lima, aims to achieve a high level of protection of human health and safety, through the Notificación Sanitaria Obligatoria (NSO), control and surveillance of cosmetic products in the community market. 

Decision 833 regulates the production, storage, importation, and marketing of cosmetic products in the four members countries of the CAN, and states that they should not harm human health when used under normal or reasonable conditions, particularly considering their cosmetic forms, precautions, labeling, and instructions for use and disposal, as well as any other indication or information on the product.

In addition, the new standard states that substances or formulations intended for prevention, treatment, or diagnosis of diseases, intended to be ingested, inhaled, injected, or implanted in the human body, will not be considered cosmetic products.

This regulation also includes specific provisions on the recognition of the NSO among the four-member countries, as well as the elimination of the Free Sale Certificate for imported products, among others.

Source: Andean Community of Nations

Learn more about our cosmetic products market at 997556699 or by mail info@pharmaconsulting.pe